Cingulate Therapeutics

New Filing
CIK: 0001593151·Pharmaceuticals·DELAWARE·Filed: Jul 11, 2018
Total Offering

Indefinite

Amount Sold

$15,600,000

Investors

133

First Sale

Nov 14, 2013

Offering Details

Type
Equity, Debt, Other: Membership Units
Exemptions
Rule 506(b), Section 4(a)(5)
Entity Type
Limited Liability Company
Non-Accredited Investors
No

Related Persons

NameRole
Louis George Van Horn
Related Person
Shane j Schaffer
Related Person
Craig Steven Gilgallon
Related Person
Matthew N Brams
Related Person
Raul R Silva
Related Person
Laurie A Myers
Related Person
Arthur B Straughn
Related Person
Patrick J Gallagher
Related Person
Jeff Hargroves
Related Person
Peter J Werth
Related Person
Jeff Conroy
Related Person

Company

Cingulate Therapeutics

1901 W. 47th Place

KANSAS CITY, KS, 66205

913-942-2302

SEC Filing

0001593151-18-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cingulate Therapeutics Form D Filing — Indefinite | FilingFlow